Ticker Details
MaxCyte, Inc. Common Stock
IPO Date:	July 26, 2021
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$78.94M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.15 | 3.03%
Avg Daily Range (30 D):	$0.03 | 3.59%
Avg Daily Range (90 D):	$0.04 | 3.22%

Institutional Daily Volume
Avg Daily Volume:	.57M
Avg Daily Volume (30 D):	1.23M
Avg Daily Volume (90 D):	.96M

Trade Size
Avg Trade Size (Sh.):	118
Avg Trade Size (Sh.) (30 D):	230
Avg Trade Size (Sh.) (90 D):	223

Institutional Trades
Total Institutional Trades:	169
Avg Institutional Trade:	$2.35M
Avg Institutional Trade (30 D):	$1.67M
Avg Institutional Trade (90 D):	$2.84M
Avg Institutional Trade Volume:	.4M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.11M
Avg Closing Trade (30 D):	$1.67M
Avg Closing Trade (90 D):	$1.67M
Avg Closing Volume:	530.47K

News

Jan 12, 2026 @ 1:05 PM MaxCyte Announces Preliminary Unaudited Fourth Qua... Source: Globe Newswire

Jul 4, 2024 @ 1:11 PM Global Transfection Technologies Market Predicted ... Source: Polaris Market Research (Pmr)

Jun 13, 2024 @ 1:55 PM Does MaxCyte (MXCT) Have the Potential to Rally 85... Source: Zacks Equity Research

Jun 13, 2024 @ 12:50 PM Recent Price Trend in MaxCyte (MXCT) is Your Frien... Source: Zacks Equity Research

May 29, 2024 @ 12:05 PM MaxCyte to Participate in William Blair 44th Annua... Source: MaxCyte, Inc

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.12	$-.12	$-.1
Diluted EPS	$-.12	$-.12	$-.09
Revenue	$6.83M	$8.51M	$10.39M
Gross Profit	$5.23M	$6.99M	$8.89M
Net Income / Loss	$-12.42M	$-12.36M	$-10.26M
Operating Income / Loss	$-14.15M	$-14.23M	$-12.3M
Cost of Revenue	$1.6M	$1.52M	$1.5M
Net Cash Flow	$-2.25M	$-8.16M	$-4.5M
PE Ratio